Evaluation of the Efficacy and Safety of ADL5945 Once Daily for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer Pain
Clinical trial NCT01275755 · COMPLETED
Trial details
- NCT number
- NCT01275755
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-19
- Primary completion
- 2011-07-15
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.